@article{TRO4902,
author = {Stefano Arcangeli and Valentina Pinzi},
title = {Quality of life after ultra-hypofractionated radiotherapy for prostate cancer: the challenge of RTOG 0938 trial},
journal = {Therapeutic Radiology and Oncology},
volume = {3},
number = {0},
year = {2019},
keywords = {},
abstract = {In the Red Journal, Lukka and colleagues reported optimal quality of life (QoL) outcomes of the NRG Oncology RTOG 0938 trial (1). This trial randomly compared two short radiation schedules of 5 and 12 fractions of 7.25 and 4.3 Gy each, respectively, for the treatment of localized, low risk prostate cancer. The primary endpoint was the proportion of patients with a change in bowel and urinary EPIC-50 score at 1-year.},
issn = {2616-2768}, url = {https://tro.amegroups.org/article/view/4902}
}